Search clinical trials for: Bupropion

Total 377 results

Emory University
National Institute of Mental Health (NIMH)

Completed

Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits

Major Depression

United States
University of Malaya

Completed

Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men

Sexual Dysfunctions, Psychological | Hypoactive Sexual Desire Disorder | Erectile Dysfunctions

Malaysia
New York State Psychiatric Institute

Withdrawn

Add-on to Cognitive, Event-Related Potentials (ERP) and Electroencephalogram (EEG) Asymmetry in Affective Disorders

Depressive Illness

United States
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior

Smoking Lapse Behavior

United States
Astellas Pharma Global Development, Inc.
Basilea Pharmaceutica International Ltd

Completed

Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion

Healthy Volunteers | Pharmacokinetics of Isavuconazole | Pharmacokinetics of Bupropion

United States
Mayo Clinic
National Cancer Institute (NCI); University of Minnesota

Completed

Varenicline and Bupropion for Smoking Cessation (CHANBAN)

Smoking

United States
University Health Network, Toronto
GlaxoSmithKline; H. Lundbeck A/S

Completed

Memory Functioning and Antidepressant Treatment

Depression | Major Depressive Disorder

Canada
University of California, Los Angeles

Withdrawn

Relapse Prevention in Stimulant Use Disorder

ADHD | Cognitive Function | Relapse | Stimulant Use

United States
St. Joseph's Healthcare Hamilton
Bausch Health, Canada Inc.

Active, not recruiting

A Trial Evaluating the Effectiveness of Contrave in Patients Who Have Weight Recidivism Following Bariatric Surgery (COR-WR)

Obesity

Canada
VA Office of Research and Development

Completed

VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D)

Major Depressive Disorder

United States
Orexigen Therapeutics, Inc

Completed

Bioequivalence Study Comparing Naltrexone SR/Bupropion SR Trilayer Tablets From Two Manufacturers

Healthy

United States
Orexigen Therapeutics, Inc

Completed

A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects

Obesity | Overweight

United States
ART Fertility Clinics LLC

Not yet recruiting

Effect of Antioxydant-enriched Media on Blastocyst Euploidy Rates. (GX)

Infertility | In Vitro Fertilization
University of Tartu

Completed

Investigation of Genetic Predictors of the Response to Selective Serotonin Re-uptake Inhibitors (SSRI) Treatment

Major Depression

Estonia
Centre for Addiction and Mental Health
Ontario Ministry of Health and Long Term Care

Completed

Distribution of Bupropion and Varenicline to Increase Smoking Cessation Attempts

Smoking | Smoking Cessation | Tobacco Use Disorder

Canada
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Bupropion HCI 300 mg Extended-Release Tablets Under Fasting Conditions

Depression
Brown University
National Institute on Drug Abuse (NIDA)

Completed

Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia

Tobacco Use Disorder | Schizophrenia and Disorders With Psychotic Features

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fasting Conditions

Healthy

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fed Conditions

Healthy

United States
New York State Psychiatric Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Terminated

Fluoxetine and Bupropion to Treat Patients With Depression and Alcoholism

Depression | Alcoholism | Suicidal Behavior

United States
University of Minnesota
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Varenicline and Smoking Cessation in Schizophrenia (VSCS)

Smoking Cessation | Schizophrenia

United States
University of California, Los Angeles
National Institute of Mental Health (NIMH)

Completed

Personalized Indicators for Predicting Response to SSRI Treatment in Major Depression (The PRISE-MD Study)

Depression

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fasting Conditions

Healthy

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fed Conditions

Healthy

United States
University of Texas Southwestern Medical Center
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder (ADAPT-2)

Methamphetamine Use Disorder

United States
Vanderbilt University Medical Center

Completed

Connectivity Affecting the Antidepressant REsponse Study (CAARE)

Major Depressive Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

The Effects of Memantine and Bupropion on Acute, Reinforcing, and Conditioned Effects of Cigarettes - 1

Tobacco Use Disorder

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Bupropion Sustained Release 150 mg Tablets Under Fasting Conditions

Healthy

United States
Fundación Pública Andaluza para la gestión de la...
Andaluz Health Service; European Commission

Completed

So-Lo-Mo Intervention Applied to the Smoking Cessation Process (So-Lo-Mo)

Smoking Cessation | Health Behavior | Lifestyle-related Condition
GlaxoSmithKline

Completed

Sexual Functioning Study With Antidepressants

Depressive Disorder, Major | Major Depressive Disorder (MDD)

United States
Lisa Sanderson Cox, PhD
National Cancer Institute (NCI)

Completed

Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking

Kidney Cancer | Cervical Cancer | Leukemia | Head and Neck Cancer | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Tobacco Use Disorder | Lung Cancer | Bladder Cancer | Liver Cancer

United States
Columbia University
University of Pennsylvania; Washington University School of Medicine; National... and other collaborators

Completed

Comparison of Depression Interventions After Acute Coronary Syndrome (CODIACS)

Depression | Acute Coronary Syndrome

United States
Oslo University Hospital
Orexigen Therapeutics, Inc

Withdrawn

Naltrexone/Bupropion (Mysimba) to Optimize Weight Outcomes After Obesity Surgery

Obesity
University of Pittsburgh
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Connect to Quit for Smoking (CTQ)

Smoking | Smoking Cessation

United States
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Medication Change for Non-Responders

Obesity | Binge-Eating Disorder

United States
Gangnam Severance Hospital

Completed

Effects of Mediterranean Diet and Naltrexone/Bupropion Treatment in Obese Breast Cancer Patients

Obesity | Breast Cancer | Overweight

Korea, Republic of
University of Tennessee
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Nicotine Patch and Bupropion to Reduce Smoking Rates in Younger, Low-Income, and Minority Individuals

Tobacco Use Disorder

United States
Orexigen Therapeutics, Inc

Completed

Efficacy and Safety Study of Combination Therapy to Treat Uncomplicated Obesity

Obesity

United States
American Regent, Inc.

Not yet recruiting

Tralement Versus a Fixed-dose Trace Element Combination Product of Zinc, Copper, and Selenious Acid to Evaluate Product Safety in Pediatric Patients >3 to 17 Years of Age Requiring Long-term Parenteral Nutrition

Manganese Safety in Pediatric Patients
Axsome Therapeutics, Inc.

Completed

Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)

Major Depressive Disorder | Treatment Resistant Depression

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Paroxetine/Bupropion in Depression With Suicide Attempt or Thoughts: fMRI Study

Depression | Suicidal Ideation

United States
University of California, San Francisco
National Institute on Drug Abuse (NIDA)

Completed

Maintaining Nonsmoking: Older Smokers - 1

Tobacco Use Disorder

United States
University of Minnesota
National Institute on Drug Abuse (NIDA)

Unknown

Study of Bupropion Versus Bupropion + Naltrexone for Smoking Cessation

Tobacco Use Disorder

United States
North Suffolk Mental Health Association

Completed

Nicotine Replacement Therapy for Smoking Cessation in Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Orexigen Therapeutics, Inc

Completed

Safety and Efficacy of Different Combinations of Zonisamide-CR Plus Bupropion-SR to Treat Uncomplicated Obesity

Obesity

United States
David Steffens
National Institute of Mental Health (NIMH)

Recruiting

Predictors of Cognitive Outcomes in Geriatric Depression (NBOLD)

Stress | Cognitive Change | Major Depressive Disorder | Neuroticism

United States
Shanghai Mental Health Center
University of Massachusetts, Worcester

Completed

Naltrexone and Bupropion Combination on Obese,Smoking Patients With Schizophrenia

Schizophrenia | Obese | Cigarette-smoking
Orexigen Therapeutics, Inc

Terminated

Naltrexone/Bupropion Cardiovascular Outcomes Study

Cardiovascular Diseases | Obesity

United States
Orexigen Therapeutics, Inc

Completed

Study to Evaluate the Effect of Naltrexone and Bupropion Combination on the Pharmacokinetics of Metformin in Healthy Participants

Healthy Subjects
Currax Pharmaceuticals

Recruiting

Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE) (INFORMUS)

Obesity

United States

Search clinical trials for: Bupropion

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations